HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Y Neuzillet Selected Research
Y Neuzillet Research Topics
Disease
20
Neoplasms (Cancer)
01/2023 - 12/2008
11
Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 01/2012
9
Non-Muscle Invasive Bladder Neoplasms
04/2022 - 11/2012
9
Carcinoma (Carcinomatosis)
01/2021 - 03/2011
6
Neoplasm Metastasis (Metastasis)
12/2014 - 07/2008
5
Renal Cell Carcinoma (Grawitz Tumor)
11/2019 - 07/2008
4
Carcinoma in Situ
01/2022 - 01/2012
4
Prostatic Neoplasms (Prostate Cancer)
09/2018 - 03/2011
3
Kidney Neoplasms (Kidney Cancer)
03/2011 - 07/2008
2
Pathologic Constriction (Stenosis)
09/2021 - 10/2014
2
Hematuria
11/2019 - 10/2013
2
Hydronephrosis
02/2013 - 01/2012
2
Wounds and Injuries (Trauma)
10/2012 - 01/2012
1
Stress Urinary Incontinence
09/2023
1
COVID-19
04/2022
1
Anastomotic Leak
09/2021
1
Thrombosis (Thrombus)
09/2021
1
Infections
01/2021
1
Urolithiasis
01/2018
1
Hypogonadism (Hypergonadotropic Hypogonadism)
11/2016
1
Chronic Kidney Failure (Chronic Renal Failure)
11/2016
1
Chronic Renal Insufficiency
11/2016
1
Urologic Neoplasms (Urological Cancer)
11/2014
1
Urinary Fistula
10/2014
1
Fistula
10/2014
1
Erectile Dysfunction
03/2013
1
Obesity
10/2012
1
Mucositis
03/2011
1
Cystitis
03/2010
1
Surgical Blood Loss
09/2009
1
Cysts
12/2008
1
Kidney Calculi (Kidney Stone)
12/2008
Drug/Important Bio-Agent (IBA)
5
Mitomycin (Mitomycin-C)
FDA Link
Generic
04/2022 - 11/2012
2
Epirubicin (Ellence)
FDA Link
Generic
04/2022 - 04/2022
2
Testosterone (Sustanon)
FDA Link
11/2016 - 12/2015
2
MTOR Inhibitors
IBA
03/2011 - 03/2011
1
aristolochic acid I (aristolochic acid)
IBA
01/2021
1
Therapeutic Uses
IBA
11/2019
1
Carcinogens
IBA
11/2019
1
Cisplatin (Platino)
FDA Link
Generic
10/2018
1
Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)
IBA
01/2016
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
01/2016
1
Biomarkers (Surrogate Marker)
IBA
12/2014
1
Androgens
IBA
10/2013
1
orteronel
IBA
10/2013
1
enzalutamide
IBA
10/2013
1
Abiraterone Acetate
IBA
10/2013
1
Aspartic Acid (Aspartate)
FDA Link
03/2013
1
arginine aspartate
IBA
03/2013
1
Adenosine Monophosphate (AMP)
IBA
03/2013
1
Arginine (L-Arginine)
FDA Link
03/2013
1
Solutions
IBA
01/2012
1
Interferons
IBA
03/2011
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
03/2011
1
Zoledronic Acid (Zometa)
FDA Link
03/2011
1
Sunitinib (Sutent)
FDA Link
03/2011
1
Sorafenib (BAY 43-9006)
FDA Link
03/2011
1
Gonadotropin-Releasing Hormone (GnRH)
FDA Link
03/2011
1
Bevacizumab (Avastin)
FDA Link
03/2011
1
cabazitaxel
FDA Link
03/2011
1
pazopanib
FDA Link
03/2010
1
Angiogenesis Inhibitors
IBA
07/2008
Therapy/Procedure
13
Cystectomy
01/2023 - 01/2012
11
Therapeutics
01/2023 - 03/2010
6
Drug Therapy (Chemotherapy)
11/2019 - 03/2011
4
Intravesical Administration
04/2022 - 11/2012
4
Neoadjuvant Therapy
01/2021 - 12/2014
4
Kidney Transplantation
01/2021 - 10/2012
4
Nephroureterectomy
11/2020 - 03/2012
4
Lymph Node Excision (Lymph Node Dissection)
12/2014 - 06/2012
4
Nephrectomy
03/2010 - 07/2008
3
Transplantation
01/2021 - 12/2012
3
Immunotherapy
11/2019 - 03/2011
3
Prostatectomy (Retropubic Prostatectomy)
07/2019 - 12/2015
2
Radiotherapy
10/2013 - 06/2012
1
Suburethral Slings (Tension-Free Vaginal Tape)
09/2023
1
Adjuvant Chemotherapy
01/2022
1
Autologous Transplantation
09/2021
1
Stents
09/2021
1
Reoperation
09/2021
1
Operative Surgical Procedures
01/2020
1
Nephrotomy
01/2018
1
Urinary Diversion (Ileal Conduit)
11/2017
1
Palliative Care (Palliative Therapy)
10/2013
1
Metastasectomy
10/2013
1
Castration
10/2013
1
Cryosurgery
12/2012
1
Conservative Treatment
07/2012
1
Chemoradiotherapy
01/2012
1
Organ Transplantation
03/2010
1
Lasers (Laser)
12/2008
1
Anesthesia
12/2008